These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 11242898

  • 1. [Screening for early detection of prostate cancer (first experience in Israel)].
    Neheman A, Shotland Y, Metz Y, Stein A.
    Harefuah; 2001 Jan; 140(1):4-10, 88, 87. PubMed ID: 11242898
    [Abstract] [Full Text] [Related]

  • 2. Prostate cancer. Mortality and morbidity after non-curative treatment with aspects on diagnosis and treatment.
    Aus G.
    Scand J Urol Nephrol Suppl; 1994 Jan; 167():1-41. PubMed ID: 7542397
    [Abstract] [Full Text] [Related]

  • 3. Assessing individual risk for prostate cancer.
    Nam RK, Toi A, Klotz LH, Trachtenberg J, Jewett MA, Appu S, Loblaw DA, Sugar L, Narod SA, Kattan MW.
    J Clin Oncol; 2007 Aug 20; 25(24):3582-8. PubMed ID: 17704405
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day).
    Srinualnad S, Charoenkraikamol C, Toraksa S, Uiprasertkul M, Amornvesukit T, Taweemonkongsap T, Udompunturak S, Nualyong C, Tantiwong A.
    J Med Assoc Thai; 2006 Jan 20; 89(1):37-42. PubMed ID: 16583579
    [Abstract] [Full Text] [Related]

  • 5. The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC), Rotterdam.
    Gosselaar C, Roobol MJ, Roemeling S, Schröder FH.
    Eur Urol; 2008 Sep 20; 54(3):581-8. PubMed ID: 18423977
    [Abstract] [Full Text] [Related]

  • 6. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
    Men S, Cakar B, Conkbayir I, Hekimoglu B.
    J Exp Clin Cancer Res; 2001 Dec 20; 20(4):473-80. PubMed ID: 11876539
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of digital rectal examination and prostate specific antigen in early detection of prostate cancer.
    Galić J, Karner I, Cenan L, Tucak A, Hegedus I, Pasini J, Bilandzija-Peranović M, Mihaljević S.
    Coll Antropol; 2003 Dec 20; 27 Suppl 1():61-6. PubMed ID: 12955893
    [Abstract] [Full Text] [Related]

  • 10. Prostate biopsy: who, how and when. An update.
    Djavan B, Milani S, Remzi M.
    Can J Urol; 2005 Feb 20; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165
    [Abstract] [Full Text] [Related]

  • 11. Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL.
    Canby-Hagino E, Hernandez J, Brand TC, Troyer DA, Higgins B, Ankerst DP, Thompson IM, Leach RJ, Parekh DJ.
    Urology; 2007 Oct 20; 70(4):748-52. PubMed ID: 17991549
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Screening for prostate cancer: updated experience from the Tyrol study.
    Horninger W, Berger A, Pelzer A, Klocker H, Oberaigner W, Schönitzer D, Severi G, Robertson C, Boyle P, Bartsch G.
    Can J Urol; 2005 Feb 20; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158
    [Abstract] [Full Text] [Related]

  • 14. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME.
    Clin Lab Sci; 2001 Feb 20; 14(2):102-7. PubMed ID: 15625982
    [Abstract] [Full Text] [Related]

  • 15. The early detection of prostate carcinoma with prostate specific antigen: the Washington University experience.
    Smith DS, Humphrey PA, Catalona WJ.
    Cancer; 1997 Nov 01; 80(9):1852-6. PubMed ID: 9351559
    [Abstract] [Full Text] [Related]

  • 16. Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.
    Thompson IM, Pauler Ankerst D, Chi C, Goodman PJ, Tangen CM, Lippman SM, Lucia MS, Parnes HL, Coltman CA.
    J Clin Oncol; 2007 Jul 20; 25(21):3076-81. PubMed ID: 17634486
    [Abstract] [Full Text] [Related]

  • 17. Increasing level of prostate-specific antigen and prostate cancer risk factors among 193 men examined in screening procedure.
    Opalińska E, Michalak A, Stoma F, Latalski M, Goniewicz M.
    Ann Univ Mariae Curie Sklodowska Med; 2003 Jul 20; 58(2):57-63. PubMed ID: 15323167
    [Abstract] [Full Text] [Related]

  • 18. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
    Faria EF, Carvalhal GF, dos Reis RB, Tobias-Machado M, Vieira RA, Reis LO, Nogueira L, Machado RD, Freitas CH, Magnabosco WJ, Mauad EC, Carvalho AL.
    BJU Int; 2012 Dec 20; 110(11 Pt B):E653-7. PubMed ID: 22892057
    [Abstract] [Full Text] [Related]

  • 19. Is a digital rectal examination necessary in the diagnosis and clinical staging of early prostate cancer?
    Philip J, Dutta Roy S, Ballal M, Foster CS, Javlé P.
    BJU Int; 2005 May 20; 95(7):969-71. PubMed ID: 15839915
    [Abstract] [Full Text] [Related]

  • 20. High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey.
    Bunker CH, Patrick AL, Konety BR, Dhir R, Brufsky AM, Vivas CA, Becich MJ, Trump DL, Kuller LH.
    Cancer Epidemiol Biomarkers Prev; 2002 Aug 20; 11(8):726-9. PubMed ID: 12163325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.